{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:35:11Z","timestamp":1791668111723,"version":"4.3.4"},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016399","name":"Universit\u00e9 de Reims Champagne-Ardenne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Cystic fibrosis (CF) is the most common genetic diseases in the Caucasian population. CFTR defects, the most common being F508del, lead to abnormal mucus accumulation. Respiratory failure caused by the resulting chronic infections is the leading cause of death in people with cystic fibrosis (pwCF). <jats:italic>Pseudomonas aeruginosa<\/jats:italic> is a major pathogen in CF and is responsible for a deterioration of respiratory function in pwCF. The increase of antibiotic-resistant <jats:italic>P. aeruginosa<\/jats:italic> strains encourages the search for alternative therapeutics for treating <jats:italic>P. aeruginosa<\/jats:italic> infection. <jats:italic>In vitro<\/jats:italic> studies have shown an interest in (R)-roscovitine (roscovitine) in the fight against bacterial infection in pwCF. Here we show a nuanced effect of roscovitine on ASL bactericidal activity and CF bronchial epithelium protection against <jats:italic>P. aeruginosa<\/jats:italic>. Using a 3D model of fully differentiated and functional F508del-CFTR human bronchial epithelium, we evidenced (i) an enhancement of the bactericidal activity of the airway surface liquid for 25 <jats:italic>\u03bc<\/jats:italic>M roscovitine but (ii) no limitation of the dynamic of the epithelium destruction upon roscovitine treatment whatever the concentrations. Our findings shed light on reasons for the lack of beneficial effects to prevent <jats:italic>P. aeruginosa<\/jats:italic> infection in pwCF treated with roscovitine in the ROSCO-CF clinical trial. We anticipate that our findings would have significant therapeutic implications in seeking to optimize roscovitine analogs.<\/jats:p>","DOI":"10.1371\/journal.pone.0321996","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T17:27:01Z","timestamp":1746466021000},"page":"e0321996","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Roscovitine enhances the bactericidal activity of the airway surface liquid of the cystic fibrosis bronchial epithelium but does not protect against Pseudomonas aeruginosa infection"],"prefix":"10.1371","volume":"20","author":[{"given":"Adrien","family":"Maupas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00eblle","family":"Muggeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Moussalih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Sage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Luczka-Maj\u00e9rus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Coraux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3795-0398","authenticated-orcid":true,"given":"Thomas","family":"Guillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"issue":"4","key":"pone.0321996.ref001","doi-asserted-by":"crossref","first-page":"e00019-18","DOI":"10.1128\/CMR.00019-18","article-title":"Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis","volume":"31","author":"MD Parkins","year":"2018","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"pone.0321996.ref002","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1378\/chest.09-0132","article-title":"Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005","volume":"136","author":"S Razvi","year":"2009","journal-title":"Chest"},{"key":"pone.0321996.ref003","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2334-6-4","article-title":"Microbiology of airway disease in a cohort of patients with cystic fibrosis","volume":"6","author":"A Lambiase","year":"2006","journal-title":"BMC Infect Dis"},{"issue":"6","key":"pone.0321996.ref004","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jcf.2019.04.009","article-title":"Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung","volume":"18","author":"S Malhotra","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"10","key":"pone.0321996.ref005","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/oxfordjournals.aje.a008664","article-title":"Determinants of mortality from cystic fibrosis in Canada, 1970-1989","volume":"143","author":"M Corey","year":"1996","journal-title":"Am J Epidemiol"},{"issue":"1","key":"pone.0321996.ref006","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10198-015-0759-9","article-title":"Cost-of-illness analysis and regression modeling in cystic fibrosis: a retrospective prevalence-based study","volume":"18","author":"T Ml\u010doch","year":"2017","journal-title":"Eur J Health Econ"},{"key":"pone.0321996.ref007","doi-asserted-by":"crossref","first-page":"665759","DOI":"10.3389\/fcimb.2021.665759","article-title":"The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies","volume":"11","author":"RF Langendonk","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"pone.0321996.ref008","doi-asserted-by":"crossref","first-page":"21700","DOI":"10.1038\/s41598-020-78817-x","article-title":"(R)-Roscovitine and CFTR modulators enhance killing of multi-drug resistant Burkholderia cenocepacia by cystic fibrosis macrophages","volume":"10","author":"CL Shrestha","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"pone.0321996.ref009","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000444256","article-title":"Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis","volume":"8","author":"L Meijer","year":"2016","journal-title":"J Innate Immun"},{"issue":"47","key":"pone.0321996.ref010","doi-asserted-by":"crossref","first-page":"E6486","DOI":"10.1073\/pnas.1518966112","article-title":"TRPC6 channel translocation into phagosomal membrane augments phagosomal function","volume":"112","author":"V Riazanski","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"pone.0321996.ref011","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1165\/rcmb.2021-0406OC","article-title":"Roscovitine Worsens Mycobacterium abscessus Infection by Reducing DUOX2-mediated Neutrophil Response","volume":"66","author":"V Le Moigne","year":"2022","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"pone.0321996.ref012","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jcf.2021.10.013","article-title":"Safety and pharmacokinetics of Roscovitine (Seliciclib) in cystic fibrosis patients chronically infected with Pseudomonas aeruginosa, a randomized, placebo-controlled study","volume":"21","author":"L Meijer","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"3","key":"pone.0321996.ref013","doi-asserted-by":"crossref","first-page":"e1011221","DOI":"10.1371\/journal.ppat.1011221","article-title":"Current concepts on Pseudomonas aeruginosa interaction with human airway epithelium","volume":"19","author":"A Muggeo","year":"2023","journal-title":"PLoS Pathog"},{"issue":"3","key":"pone.0321996.ref014","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/rr25","article-title":"Epithelial antimicrobial peptides in host defense against infection","volume":"1","author":"R Bals","year":"2000","journal-title":"Respir Res"},{"issue":"1","key":"pone.0321996.ref015","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.1038\/s41598-019-42751-4","article-title":"Airway surface liquid acidification initiates host defense abnormalities in Cystic Fibrosis","volume":"9","author":"J Simonin","year":"2019","journal-title":"Sci Rep"},{"issue":"2","key":"pone.0321996.ref016","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/path.5439","article-title":"FHITlow \/pHER2high signature in non-small cell lung cancer is predictive of anti-HER2 molecule efficacy","volume":"251","author":"J Da Silva","year":"2020","journal-title":"J Pathol"},{"issue":"3","key":"pone.0321996.ref017","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/path.4471","article-title":"Cystic fibrosis airway epithelium remodelling: involvement of inflammation","volume":"235","author":"D Adam","year":"2015","journal-title":"J Pathol"},{"issue":"3","key":"pone.0321996.ref018","doi-asserted-by":"crossref","first-page":"L543","DOI":"10.1152\/ajplung.00256.2003","article-title":"Dynamic interaction between airway epithelial cells and Staphylococcus aureus","volume":"287","author":"MCA da Silva","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"pone.0321996.ref019","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.3892\/mmr.2015.3868","article-title":"Cyclin-dependent kinase 5 regulates the proliferation, motility and invasiveness of lung cancer cells through its effects on cytoskeletal remodeling","volume":"12","author":"J-L Liu","year":"2015","journal-title":"Mol Med Rep"},{"issue":"9","key":"pone.0321996.ref020","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nm1468","article-title":"Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis","volume":"12","author":"AG Rossi","year":"2006","journal-title":"Nat Med"},{"issue":"1","key":"pone.0321996.ref021","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.2119\/molmed.2012.00033","article-title":"R-roscovitine reduces lung inflammation induced by lipoteichoic acid and Streptococcus pneumoniae","volume":"18","author":"AJ Hoogendijk","year":"2012","journal-title":"Mol Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0321996","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T17:27:08Z","timestamp":1746466028000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0321996"}},"subtitle":[],"editor":[{"given":"Subhra","family":"Mohapatra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0321996","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,5]]}}}